NexHand Inc.
Precisely quantifying SUI severity and sling tension
This article was originally published in Start Up
Executive Summary
NexHand Inc. has developed proprietary, sensor-based "smart surgical glove" technology designed to enable physicians to assess the severity of stress urinary incontinence. Its technology has been developed into two disposable products: the first is a noninvasive diagnostic tool for assessing the severity of SUI in the clinical setting, the UroGlove, and the second is a probe-based sensor for determining proper tensioning of urethral slings during surgery.
You may also be interested in...
Medtech Start-Ups Innovate In Urinary Incontinence
Angel- and venture-backed medtech start-ups are working to fill the tremendous unmet need for alternative device options for treating (not just managing) female urinary incontinence a condition that has a significant impact on quality of life for millions of women. In this issue we profile Floelle, InControl Medical, NexHand, and Solace Therapeutics.
ImmunoGen’s Elahere Data In Avastin-Naïve Ovarian Cancer Prompt Discussion About Earlier Use
The presenter on the MIRASOL study called the data “practice changing,” while the discussant cited Sutro’s STRO-002 as a potential option for patients with low folate receptor alpha expression.
ASCO - Servier’s Vorasidenib Puts The Brakes On Brain Cancer In INDIGO
Servier’s targeted therapy, vorasidenib, can effectively delay the need for more drastic treatment in patients with low-grade glioma, but increases in liver enzymes including two cases of Hy’s law have cast some shade over the INDIGO data.